NASDAQ: ISPCIspecimen Inc Stock
$0.30-0.04 (-11.76%)
Updated Apr 23, 2024
ISPC Price
$0.30
Fair Value Price
N/A
Market Cap
$2.68M
52 Week Low
$0.20
52 Week High
$1.89
P/E
-0.24x
P/B
0.28x
P/S
0.46x
PEG
N/A
Dividend Yield
N/A
Revenue
$9.93M
Earnings
-$11.10M
Gross Margin
51.4%
Operating Margin
-111.64%
Profit Margin
-111.8%
Debt to Equity
0.62
Operating Cash Flow
-$6M
Beta
0.74
Next Earnings
May 2, 2024
Ex-Dividend
N/A
Next Dividend
N/A
ISPC Overview
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide through its iSpecimen Market placplatform. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen was incorporated in 2009 and is headquartered in Lexington, MA.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ISPC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ISPC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ISPC is good value based on its book value relative to its share price (0.28x), compared to the US Diagnostics & Research industry average (4.24x)
P/B vs Industry Valuation
ISPC is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ISPC due diligence checks available for Premium users.
Be the first to know about important ISPC news, forecast changes, insider trades & much more!
ISPC News
Valuation
ISPC fair value
Fair Value of ISPC stock based on Discounted Cash Flow (DCF)
Price
$0.30
Fair Value
$0.91
Undervalued by
66.94%
ISPC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ISPC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.24x
Industry
38.97x
Market
41.92x
ISPC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.28x
Industry
4.24x
ISPC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ISPC's financial health
Profit margin
Revenue
$2.6M
Net Income
-$3.1M
Profit Margin
-119.3%
ISPC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ISPC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$15.8M
Liabilities
$6.1M
Debt to equity
0.62
ISPC's short-term assets ($8.24M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ISPC's short-term assets ($8.24M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ISPC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$345.1k
Investing
-$723.0k
Financing
$0.0
ISPC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ISPC vs Diagnostic & Research Stocks
Ispecimen Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.